Cargando…

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

Farnesoid-X receptor (FXR), as a nuclear receptor activated by bile acids, is a vital molecule involved in bile acid metabolism. Due to its expression in immune cells, FXR has a significant effect on the function of immune cells and the release of chemokines when immune cells sense changes in bile a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Mengjiao, Wang, Danfeng, Li, Xiang, Cao, Ying, Yi, Chengxue, Wiredu Ocansey, Dickson Kofi, Zhou, Yuling, Mao, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583386/ https://www.ncbi.nlm.nih.gov/pubmed/36278234 http://dx.doi.org/10.3389/fphar.2022.1016836

Ejemplares similares

Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2023)

Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
por: Xia, Yuxuan, et al.
Publicado: (2023)

The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
por: Wiredu Ocansey, Dickson Kofi, et al.
Publicado: (2023)

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
por: Xu, Xinwei, et al.
Publicado: (2022)

Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2021)

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022)

The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2019)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
por: Xu, Xinwei, et al.
Publicado: (2021)

Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020)

Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers
por: Wang, Naijian, et al.
Publicado: (2022)

Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis
por: Wei, Zhiping, et al.
Publicado: (2023)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022)

The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases
por: Zhao, Zihan, et al.
Publicado: (2023)

Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
por: Zhang, Yaqin, et al.
Publicado: (2021)

The Effects of Mesenchymal Stem Cell on Colorectal Cancer
por: Yuan, Jintao, et al.
Publicado: (2021)

Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD
por: Zhu, Yanlin, et al.
Publicado: (2020)

Improved therapeutics of modified mesenchymal stem cells: an update
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
por: Li, Hong, et al.
Publicado: (2019)

Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor
por: Tang, Kaijia, et al.
Publicado: (2022)

Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
por: Wei, Zhiping, et al.
Publicado: (2021)

The effect of students’ online learning experience on their satisfaction during the COVID-19 pandemic: The mediating role of preference
por: Li, Xinchao, et al.
Publicado: (2023)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling
por: Paraiso, Ines L., et al.
Publicado: (2021)

Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
por: Xu, Xinwei, et al.
Publicado: (2023)

Calculus Bovis Sativus Improves Bile Acid Homeostasis via Farnesoid X Receptor-Mediated Signaling in Rats With Estrogen-Induced Cholestasis
por: Xiang, Dong, et al.
Publicado: (2019)

Therapeutic Effect of Amomum villosum on Inflammatory Bowel Disease in Rats
por: Chen, Zhu, et al.
Publicado: (2018)

Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway
por: Yang, Jinyu, et al.
Publicado: (2020)

Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
por: Shao, Xuejun, et al.
Publicado: (2022)

hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
por: Wang, Yifei, et al.
Publicado: (2023)

Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine
por: Yin, Lei, et al.
Publicado: (2020)

Exosome‐mediated effects and applications in inflammatory bowel disease
por: Ocansey, Dickson K. W., et al.
Publicado: (2020)

Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid X receptor-mediated bile acid homeostasis signaling pathway in rats
por: Wang, Rulin, et al.
Publicado: (2022)

Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases
por: Festa, Carmen, et al.
Publicado: (2017)

The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016)

Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
por: Yu, Junhui, et al.
Publicado: (2020)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
por: Di Fusco, Davide, et al.
Publicado: (2019)

RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
por: Honjo, Hajime, et al.
Publicado: (2021)

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
por: Girisa, Sosmitha, et al.
Publicado: (2021)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m6audofnpm8vm98rq4khj4brk5